MDR1 gene polymorphisms: Possible association with its expression and clinicopathology characteristics in colorectal cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 3141-3145

  Samanian, Sara ^a   Mahjoubi, Frouzandeh ^a   Mahjoubi, Bahar ^b   Mirzaee, Rezvan ^b   Azizi, Rasool ^b  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemotherapy; Colorectal cancer; Iranian patients; Multi drug resistance

Indexed keywords

EID: 84863321393     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Au CG, Butler TL, Egan JR, et al. (2008). Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients, Acta Neuropathol, 116, 235-46.
2. Childs S, Ling V. (1994). The MDR superfamily of genes and its biological implications. Important Adv Oncol, 1994, 21-36.
3. Cohen A, Shank B, Friedman M (1989). Colorectal cancer. In Cancer Principles and Practice of Oncology, DeVita VT Jr, Hellman S, Rosenberg S.A. (eds): pp. 895-964.
4. Darinka TP, Petya N, Svilen M (2008). No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients, J Cancer Res Clin Oncol, 134, 317-22
5. Fojo A (1987). Expression of a multidrug-resistance gene in human tumors And tissues. Proc Nati Acad Sci USA, 84, 265-9.
6. Goldstein LJ, Galski H, Fojo A, et al (1989). Expression of a multidrug resistance Gene in human cancers. J Natl Cancer Inst, 81, 116-24.
7. Gregory D, Leonard, Tito F, et al (2003). The role of ABC transporters in clinical practice. The Oncologist, 8, 411-24.
8. Isabel M, Pilar GM, José LS, et al (2007). Tumour cells resistance in cancer therapy. Clin Transl Oncol, 9, 13-20.
9. Kimchi-Sarfaty C, Oh JM, Kim IW, et al (2007). A " silent" polymorphism in the MDR1 gene changes substrate specificity. Science, 315, 525-8.
10. Kurzawski M, Droździk M, Suchy J, et al (2005). Polymorphism in the P-glycoprotein Drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol, 61, 389-94.
11. Linn SC, Giaccone G (1995). MDR1/P-glycoprotein expression in colon cancer. Eur J Cancer, 31, 1291-4.
12. Longley D, Johnston (2005). Molecular mechanisms of drug resistance. J Pathol, 2005, 275-92.
13. Luqmani YA (2005). Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract, 14, 35-48.
14. Martin Filipits (2004). Mechanisms of cancer: multidrug resistance. Drug Discovery Today, 1, no2.
15. Meijer GA, Schroeijers AB, Flens MJ, et al (1999). Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occur early in colorectal carcinogenesis. J Clinical Pathology, 52, 450-4.
16. Peters WH, Boon CE, Roelofs HM, et al (1992). Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology, 103, 448-55.
17. Tokunaga Y, Hosogi H, Hoppou T, et al (2001). Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery. Oncol Rep, 8, 815-9.
18. Toshiyuki S (2005). MDR1 genotype-related pharmacokinetics: fact or fiction? Drug Metab Pharmacokinetics, 20, 391-414.
19. Turgut S, Yaren A, Kursunluoglu R, Turgut G (2007). MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res, 38, 539-44.
20. van der Deen M, de Vries EG, Timens W, et al (2005). ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res, 6, 59.